HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eun-Ju Hong Selected Research

Metalloproteases (Metalloproteinases)

12/2022Anti-inflammatory effect of Gyeji-tang in a chronic obstructive pulmonary disease mouse model induced by cigarette smoke and lipopolysaccharide.
1/2022Yijin-Tang Attenuates Cigarette Smoke and Lipopolysaccharide-Induced Chronic Obstructive Pulmonary Disease in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eun-Ju Hong Research Topics

Disease

2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2023 - 01/2022
2Chronic Obstructive Pulmonary Disease (COPD)
12/2022 - 01/2022
1Inflammation (Inflammations)
01/2024
1Liver Diseases (Liver Disease)
01/2024
1Carcinogenesis
01/2023
1Neoplasms (Cancer)
01/2023
1Necrosis
12/2022
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022
1Fibrosis (Cirrhosis)
01/2022

Drug/Important Bio-Agent (IBA)

2Testosterone (Sustanon)FDA Link
01/2023 - 01/2022
2InterleukinsIBA
01/2023 - 12/2022
2Metalloproteases (Metalloproteinases)IBA
12/2022 - 01/2022
2SmokeIBA
12/2022 - 01/2022
2LipopolysaccharidesIBA
12/2022 - 01/2022
1CytokinesIBA
01/2024
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2024
1Interleukin-17 (Interleukin 17)IBA
01/2023
1Transforming Growth Factor beta (TGF-beta)IBA
12/2022
1NF-kappa B (NF-kB)IBA
12/2022
1RoflumilastIBA
12/2022
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1CollagenIBA
01/2022
1yijin-tangIBA
01/2022
1Therapeutic UsesIBA
01/2022

Therapy/Procedure

1Therapeutics
01/2023
1Intranasal Administration
12/2022